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therosclerotic plaque forms in regions of the
vasculature exposed to disturbed ﬂow. NF-
 
 
 
B
activation by ﬂuid ﬂow, leading to expression of
target genes such as E-selectin, ICAM-1, and VCAM-1,
may regulate early monocyte recruitment and fatty streak
formation. Flow-induced NF-
 
 
 
B activation is downstream
of conformational activation of integrins, resulting in new
integrin binding to the subendothelial extracellular matrix
and signaling. Therefore, we examined the involvement
of the extracellular matrix in this process. Whereas en-
dothelial cells plated on ﬁbronectin or ﬁbrinogen activate
A
 
NF-
 
 
 
B in response to ﬂow, cells on collagen or laminin do
not. In vivo, ﬁbronectin and ﬁbrinogen are deposited at
atherosclerosis-prone sites before other signs of athero-
sclerosis. Ligation of integrin 
 
 
 
2
 
 
 
1 on collagen prevents
ﬂow-induced NF-
 
 
 
B activation through a p38-dependent
pathway that is activated locally at adhesion sites. Fur-
thermore, altering the extracellular matrix to promote
p38 activation in cells on ﬁbronectin suppresses NF-
 
 
 
B
activation, suggesting a novel therapeutic strategy for
treating atherosclerosis.
 
Introduction
 
Atherosclerotic plaque develops in response to a localized in-
flammatory reaction in the vessel wall (Ross, 1999). Although
known risk factors for atherosclerosis, such as hyperlipidemia,
hypertension, diabetes, and smoking, play major roles in the in-
cidence and progression of the disease, these factors are uni-
form throughout the circulation. The observation that athero-
sclerotic plaque forms preferentially at sites of disturbed blood
flow (VanderLaan et al., 2004) suggests that flow patterns can
regulate the chronic inflammation associated with atherogene-
sis (Caro et al., 1969; Ku et al., 1985; Glagov et al., 1988). In
support of this idea, application of prolonged laminar flow to
endothelial cells in culture is antiinflammatory and atheroprotec-
tive, whereas disturbed flow stimulates endothelial cell turnover,
expression of prothrombotic and proinflammatory proteins,
and altered redox regulation (Topper et al., 1996; Mohan et
al., 1997; De Keulenaer et al., 1998; Brooks et al., 2002).
These data suggest that disturbed flow patterns initiate the local
inflammatory reaction seen during atherosclerosis, with ampli-
fication of lesions by humoral risk factors driving progression
of the disease.
The NF-
 
 
 
B family of transcription factors are involved in
numerous cellular processes, including differentiation, inflam-
mation, proliferation, and apoptosis, and are postulated to con-
tribute to atherogenesis (Collins and Cybulsky, 2001; Kutuk
and Basaga, 2003). Current data implicate NF-
 
 
 
B as a key reg-
ulator of shear stress–induced inflammatory gene expression.
NF-
 
 
 
B dimers, particularly the p50/p65 heterodimer, bind to a
shear stress responsive element found in the promoter of several
atherogenic genes, including ICAM-1, VCAM-1, and MCP-1
(monocyte chemotactic protein-1), which regulate monocyte
recruitment, as well as PDGF, which stimulates smooth muscle
growth and migration (Resnick et al., 1993; Khachigian et al.,
1995; Huo and Ley, 2001). NF-
 
 
 
B expression and activity, as
well as ICAM-1 and VCAM-1 expression, are elevated in ath-
erosclerosis-prone regions before or in the absence of fatty
streak formation, indicating that they are very early events in
atherosclerotic progression (Brand et al., 1996; Nakashima et
al., 1998; Iiyama et al., 1999; Wilson et al., 2000). In vitro,
disturbed shear stimulates prolonged NF-
 
 
 
B activation and
NF-
 
 
 
B–dependent gene expression; in contrast, acute onset of
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laminar shear stress activates NF-
 
 
 
B but only transiently
(Lan et al., 1994; Khachigian et al., 1995; Mohan et al.,
1997). We hypothesize that these differences in signaling
pathways induced by laminar versus disturbed flow are due
in part to differences in adaptation mechanisms, such that
changes in flow velocity and direction associated with dis-
turbed flow prevents down-regulation of the responses so that
signals activated transiently by laminar flow are sustained in
disturbed flow. Thus, data from both in vivo and in vitro mod-
els suggest that NF-
 
 
 
B contributes to the initiation of athero-
sclerosis by fluid shear stress.
Studies in vitro have shown that acute onset of laminar
shear triggers conversion of integrins to a high affinity state,
followed by their binding to the subendothelial ECM (Tzima et
al., 2001). Resultant integrin signaling mediates activation of
NF-
 
 
 
B through the small GTPase Rac (Tzima et al., 2002).
Endothelial cells normally reside on a basement membrane
comprised mainly of collagen (Coll) IV and laminin (LN). Coll
binds primarily integrins 
 
 
 
2
 
 
 
1 and 
 
 
 
1
 
 
 
1, whereas LN binds
mainly 
 
 
 
6
 
 
 
1 and 
 
 
 
6
 
 
 
4 (Belkin and Stepp, 2000; Heino, 2000).
Ligation of these integrins is associated with a quiescent cell
phenotype, consistent with the low turnover observed in endo-
thelial cells in vivo (Schwartz and Assoian, 2001). Inflamma-
tion or injury can trigger the deposition of transitional ECM
proteins such as fibronectin (FN) and fibrinogen (FG) into the
subendothelial matrix (Sechler et al., 1998). In endothelial
Figure 1. Shear stress–induced NF- B acti-
vation is matrix specific. (A) BAE cells plated
on Coll I, LN, FN, or FG for 4 h were sheared
for 60 min, and p65 localization was as-
sessed by immunocytochemistry. The percent-
age of cells showing nuclear staining for NF- B
was determined. Values are means   SD
( 100 cells counted per condition per experi-
ment; n   3). *, P   0.05; **, P   0.01. A
representative p65 stain for these conditions
is shown on the right. (B) Endothelial cells
were grown on different matrix proteins and
sheared for 0, 5, 15, 30, and 60 min. Phos-
phorylation of p65 on Ser536 was assessed
by immunoblotting total cell lysates with a
phosphorylation site-specific antibody. Values
are means   SD following normalization for
total p65 (n    4). A representative blot is
shown for each condition. (C) Human umbili-
cal vein endothelial cells were plated on differ-
ent matrix proteins and sheared for 5 h, and
the level of ICAM-1 expression was assessed
by Western blotting. Densitometric quantifica-
tion was normalized to actin. n   3; *, P  
0.05. Immunocytometric staining for ICAM-1
surface expression is shown on the right. 
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cells, FN primarily ligates 
 
 
 
5
 
 
 
1 whereas FG ligates 
 
 
 
v
 
 
 
3, al-
though other integrins may also be involved. Signals from
 
 
 
5
 
 
 
1 and 
 
 
 
v
 
 
 
3 are associated with enhanced endothelial cell
proliferation and migration, processes important for injury-
induced endothelial remodeling (Schwartz and Assoian, 2001).
Many studies have shown that different integrins transduce dis-
tinct signals (Schwartz and Assoian, 2001). The involvement
of integrins in shear stress–dependent signaling thus suggests
that the composition of the subendothelial ECM may modulate
cellular responses to fluid flow. Therefore, we investigated the
role of the subendothelial ECM in the endothelial response to
fluid shear stress.
 
Results
 
Subendothelial matrix regulates shear 
stress–induced NF-
 
 
 
B activation
 
To test whether or not shear stress–induced NF-
 
 
 
B activation
depends on the underlying matrix, bovine aortic endothelial
(BAE) cells plated on glass slides coated with Coll I, LN, FN,
or FG for 4 h were subjected to laminar shear stress (12 dyne/cm
 
2
 
)
in a parallel plate flow chamber. NF-
 
 
 
B is normally held inac-
tive in the cytoplasm through interactions with I
 
 
 
B, but stimu-
lus-induced I
 
 
 
B degradation results in NF-
 
 
 
B nuclear targeting
and initiation of transcription (Chen and Greene, 2004; Yama-
moto and Gaynor, 2004). As previously reported for endothe-
lial cells under standard conditions (Scatena et al., 1998; Klein
et al., 2002; Guo et al., 2004), cells on FN or FG showed en-
hanced nuclear translocation of NF-
 
 
 
B after flow; in contrast,
cells on LN responded poorly and cells on Coll showed a
higher baseline under static conditions, which decreased in re-
sponse to flow (Fig. 1 A).
In addition to its nuclear targeting, numerous posttrans-
lational modifications contribute to NF-
 
 
 
B’s transcriptional
activity (Wang and Baldwin, 1998; Yang et al., 2003). Phos-
phorylation of the p65 subunit of NF-
 
 
 
B on Ser536 in the
transactivation domain alters NF-
 
 
 
B–dependent transcrip-
tion, presumably by regulating its interaction with other cis-
acting elements. In addition, this site is phosphorylated by the
I
 
 
 
B kinase (IKK) complex, and its phosphorylation is inhib-
Figure 2. Matrix remodeling and inflamma-
tory gene expression in vivo. C57/B6 mice
were fed a chow diet (A), male ApoE null
mice were fed a chow diet for 10 wk (B), and
ApoE null mice were fed a Western diet for
10 wk (C). Mice were killed and the indicated
arteries were removed and embedded in
paraffin. Serial sections were stained for FN,
FG, ICAM-1, VCAM-1, and Mac-2 and shown
at high magnification, with lower magnification
views of the entire vessels shown as insets. 
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ited by interaction with I
 
 
 
B, suggesting it is a good measure
for pathway activation. Ser536 phosphorylation was stimu-
lated in cells on FN or FG, but showed only small changes on
LN; on Coll, NF-
 
 
 
B phosphorylation showed an elevated
baseline that decreased after shear stress (Fig. 1 B). Cells on
Coll IV behaved identically to Coll I (unpublished data). This
result was expected because Coll I and IV bind the same inte-
grins (Defilippi et al., 1991; Tulla et al., 2001). To test if
these matrix-specific signals translate to altered gene expres-
sion, we assayed expression of ICAM-1, an NF-
 
 
 
B–respon-
sive gene. Both Western blotting and surface staining were
performed in human umbilical vein endothelial cells due to
poor antibody cross-reactivity with bovine ICAM-1. Both
methods showed that, in cells on Coll, ICAM-1 expression di-
minished after shear stress, whereas expression increased in
cells on FN and FG (Fig. 1 C). Thus, NF-
 
 
 
B nuclear translo-
cation, phosphorylation, and target gene expression correlate
closely. We conclude that the transitional ECM proteins FN
and FG support flow-induced NF-kB activation whereas LN
and Coll do not.
 
ECM remodeling in vivo
 
The distinct effects of different ECM proteins in flow-induced
NF-
 
 
 
B activation in vitro prompted us to ask whether or not
these effects were relevant to plaque development in vivo. To
test whether FN and FG deposition are associated with focal
expression of NF-kB target genes in atherosclerosis-prone
regions of the vasculature, these proteins were examined in
mice. Serial sections from atherosclerosis-susceptible sites were
stained for ECM proteins, for ICAM-1 and VCAM-1 as mark-
ers of NF-
 
 
 
B activation, and for the leukocyte integrin Mac-2
as a measure of monocyte recruitment. Atherosclerosis-resis-
tant C57/B6 mice and atherosclerosis-prone apolipoprotein E
(ApoE) null mice were fed either a normal chow diet or a high
fat, Western diet for 10 wk. Sites associated with atheroscle-
rotic plaque formation, such as the innominate artery and the
carotid arteries, were then analyzed by immunohistochemistry
(IHC; Nakashima et al., 1994).
In C57/B6 mice fed the low fat, chow diet, sites that are
susceptible to atherosclerosis in other models demonstrated
focal increases in ICAM-1 and VCAM-1 staining and in-
Figure 3. p38 inhibits shear stress–induced
NF- B activation on Coll. (A) BAE cells plated
on Coll, LN, FN, or FG were sheared for the
indicated times. Phosphorylation of p38 was
assessed by Western blotting with phosphory-
lation site-specific antibodies, quantified by
densitometry, and normalized to total p38.
Values are means   SD (n   3). A representa-
tive Western blot is shown for each condition.
(B) Cells were treated with the pharmacologi-
cal p38 inhibitor SB202190 (1  M for 1 h),
and NF- B nuclear translocation was assessed
with or without shear stress for 30 min.
Greater than 100 cells were counted per con-
dition per experiment; n   3; *, P   0.05;
**, P   0.01. (C) Cells were preincubated
with SB202190 and shear stress–induced
p65 phosphorylation (Ser536) was assessed
as previously described. Densitometric quanti-
fication was normalized to total p65. n   3.
(D) Cells were transiently transfected with
dominant-negative p38 (p38-AGF) and
sheared for 60 min, and p65 nuclear translo-
cation was assessed. Transfected cells were
identified by costaining for total p38. Greater
than 100 cells were counted per condition per
experiment; n   3; *, P   0.05. A representa-
tive stain is shown. 
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creased staining for FN, although no Mac-2 staining was ap-
parent (Fig. 2 A). We did not detect any change in FG (Fig. 2
A) or LN (not depicted) staining and no staining for FN in re-
gions outside these zones. ApoE null mice fed a chow diet
have elevated cholesterol and develop atherosclerotic lesions
over the course of their lifespan (Daugherty, 2002). In these
mice, similar colocalization of ICAM-1, VCAM-1, FN, and
FG was observed when nearby sections were stained (Fig. 2
B). FN has been reported in well-defined fatty streaks (Sten-
man et al., 1980; Labat-Robert et al., 1985; Shekhonin et al.,
1987; Tanouchi et al., 1992), but these data are the first evi-
dence that FN is deposited before fatty streak development.
In contrast, no changes in PECAM staining were evident (un-
published data). VCAM-1 staining in vascular smooth mus-
cle cells is indicative of smooth muscle activation and is as-
sociated with atherosclerosis, which is consistent with our
interpretation of these regions as early atherogenesis (Li et
al., 1993).
ApoE null mice fed a Western diet develop atherosclero-
sis at greatly accelerated rates (Daugherty, 2002). Under these
conditions, FN, FG, VCAM-1, and ICAM-1 staining was
strongly enhanced in atherosclerosis-prone sites compared
with C57/B6 or ApoE null mice fed a chow diet; however, no
Mac-2 staining was apparent (Fig. 2 C). As before, these
changes were restricted to atherosclerosis-prone regions near
bifurcations. Together, these data show that ECM is remod-
eled in regions of disturbed flow in vivo before other indica-
tors of atherosclerosis and that NF-
 
 
 
B activation correlates
with these changes in the subendothelial ECM. Furthermore,
conditions favoring hypercholesterolemia, such as depletion
of ApoE or a high fat diet, enhance matrix remodeling specifi-
cally at sites of disturbed flow, suggesting a potential synergy
between the atherogenic effects of hypercholesterolemia and
disturbed flow in vivo.
 
Coll-specific p38 signaling inhibits shear-
induced NF-
 
 
 
B activation
 
In addition to NF-
 
 
 
B, p38 MAP kinase is also involved in stim-
ulating inflammatory protein expression in a variety of sys-
tems. However, p38 shows differential effects on NF-
 
 
 
B,
either enhancing or suppressing NF-
 
 
 
B depending on the stim-
ulus (Schwenger et al., 1998; Alpert et al., 1999; Bowie and
O’Neill, 2000; Bradbury et al., 2001). To examine p38 in
this system, BAE cells were plated on different ECM proteins
for 4 h and effects of shear were tested. Western blotting with
an antibody against the phosphorylated and activated form of
p38 showed that shear stress stimulated a transient increase in
p38 phosphorylation in cells on Coll but not on other ECM pro-
teins (Fig. 3 A). This result is consistent with previous reports
showing that the Coll-binding integrin 
 
 
 
2
 
 
 
1 stimulates p38 ac-
tivation (Ivaska et al., 1999). To test if this Coll-specific p38
activation mediates inhibition of shear stress–induced NF-
 
 B activation, cells were preincubated with the p38 inhibitor
SB202190 (1  M for 1 h) before fluid flow. Inhibition of p38
with SB202190 restored shear stress–induced NF- B nuclear
translocation and NF- B phosphorylation in cells on Coll but
had no effect on cells on FN (Fig. 3, B and C). To confirm this
result, endothelial cells were transiently transfected with a
dominant-negative mutant of p38 (p38-AGF). This construct
did not alter baseline levels of NF- B activity but enhanced
flow-induced NF- B nuclear translocation in cells on Coll
(Fig. 3 D). Thus, selective activation of p38 mediates suppres-
sion of NF- B in cells on Coll.
Although Coll binds both integrins  2 1 and  1 1, ex-
pression of  1 1 is restricted to microvascular endothelial cells
(Defilippi et al., 1991; Heino, 2000). To test whether integrin
 2 1 mediates Coll-specific signaling after shear, endothelial
cells were pretreated with the  2 1 integrin–blocking antibody
R2-8C8 (20  g/ml for 30 min) or, as a control, with the non-
Figure 4. Integrin   2 1 mediates p38 activation
and NF- B inhibition. (A) BAE cells were incubated
for 30 min with either the  2 1 blocking (R2-8C8) or
the  2 1 nonblocking antibody (12F1) and sheared
for 5 or 30 min. Lysates were analyzed for p38 phos-
phorylation by immunoblotting. Bands were quanti-
fied by densitometry and normalized for total p38
protein. Values are means   SD (n    4). *, P  
0.05; **, P   0.01. (B) Cells on Coll were incubated
with 12F1 or R2-8C8 and sheared for 5 or 30 min,
and the phosphorylation of p65 was analyzed by im-
munoblotting. Bands were quantified by densitometry
and normalized for total p65. **, P   0.01 (n   5).
(C) Cells plated on Coll I or FN were pretreated with
the p38 inhibitor SB202190 (1  M for 1 h) and inte-
grin ligation was induced with the  1 integrin–activat-
ing antibody TS2/16 (15  g/ml for 1 h). p65 local-
ization was assessed by immunostaining, and the
percentage of cells showing nuclear localization was
scored (n   3; *, P   0.05). (D) TS2/16-induced
p65 phosphorylation of p65 on Ser536 was as-
sessed by Western blotting. Bands were quantified by
densitometry and normalized to total p65 (n   3–6).JCB • VOLUME 169 • NUMBER 1 • 2005 196
blocking  2 1 antibody 12F1 (20  g/ml for 30 min). With this
short exposure to blocking antibodies, we can inhibit new inte-
grin binding without significantly affecting existing adhesions or
cytoskeletal structure (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200410073/DC1). Blocking  2 1 integrin
ligation prevented the shear stress–induced activation of p38 in
cells on Coll (Fig. 4 A) and rescued NF- B phosphorylation
(Fig. 4 B). The control antibody had no effect. Preventing new
ligation of integrin  6 1 with the blocking antibody GoH3
(20  g/ml for 30 min) did not enhance flow-induced p65 nu-
clear translocation or phosphorylation in cells on LN, instead,
the already low level of NF- B was reduced further. These re-
sults suggest  6 1 is not suppressive (Fig. S2, A–C, available
at http://www.jcb.org/cgi/content/full/jcb.200410073/DC1).
To test whether or not activating integrins, as occurs in
response to fluid flow, is sufficient to induce these pathways,
cells were treated with the  1 integrin–activating antibody
TS2/16 (15  g/ml). Antibody-induced integrin activation re-
sulted in a similar, matrix-specific nuclear translocation (Fig. 4 C)
and phosphorylation (Fig. 4 D) of NF- B on FN but not Coll.
Furthermore, TS2/16-induced NF- B activation on Coll was
rescued by the p38 inhibitor SB202190 (Fig. 4, C and D).
These data support the conclusion that integrin activation and
ECM binding initiate these pathways.
Flow-induced NF- B activation on mixed 
matrices
Cells in vivo are usually exposed to multicomponent matrices
of varying composition. To test if Coll can show dominant ef-
fects in this system, cells were plated on increasing concentra-
tions of FN in either the absence or presence of an underlying
Coll matrix. The amount of FN adsorbed to the coverslips was
assayed in separate experiments. In the absence of Coll, p65
nuclear translocation and Ser536 phosphorylation displayed a
dose-dependent increase as FN concentration increased (Fig. 5,
A and B). The dose-dependent effect reached a maximum
between 4 and 6  g of deposited FN, which corresponds to
20  g/ml in the coating solution. When examined on cover-
slips first coated with Coll, the amount of FN necessary to elicit
NF- B activation was notably higher, and maximal p65 activa-
tion was reduced even at the highest doses of FN. These results
support the notion that Coll signaling actively suppresses the
FN-dependent activation of NF- B by flow. However, suppres-
sion of signaling may work in the opposite direction because FN
deposition inhibited flow-induced p38 phosphorylation in cells
on Coll in a dose-dependent manner (Fig. 5 C).
Signaling is localized to sites of adhesion
To test if elevated p38 activity on Coll suppresses NF- B activa-
tion in a more general way, cells were treated with TNF , a cy-
tokine that strongly induces this pathway. Interestingly, no sup-
pression of TNF -induced NF- B was observed (Fig. S3 A,
available at http://www.jcb.org/cgi/content/full/jcb.200410073/
DC1). Furthermore, transfection with a constitutively active
MKK3 (MKK3 EE), a kinase that is upstream of p38 and acti-
vates p38 globally (not depicted), did not prevent the shear stress–
or TNF -induced activation of NF- B in cells on FN (Fig. S3 B).
These results appear paradoxical but could be explained
if the inhibitory p38 signal from Coll occurs locally within a
specific compartment. To test this hypothesis, endothelial cells
on Coll or FN were sheared for 5 min and active p38 was local-
ized. Cells on Coll showed colocalization of phospho-p38 with
 1 integrins, which was increased by shear stress (Fig. 6 A).
Cells on FN showed only low levels of phospho-p38 staining,
which is consistent with results from Western blotting.
The IKK complex consists of two kinase subunits (IKK 
and IKK ) and a regulatory subunit named NEMO or IKK  (Is-
rael, 2000). Numerous stimuli activate NF- B through this com-
plex, resulting in phosphorylation of the kinase subunits (Ser176/
Figure 5. Coll/FN mixed matrices. BAE cells were plated on increasing
amounts of FN with or without precoating with 10  g/ml Coll. (A) Cells
were sheared for 30 min and nuclear p65 accumulation was assessed as
previously described. The abscissa represents the amount of FN adsorbed
to the coverslips under these conditions. Values reflect the increase in p65
nuclear translocation relative to cells under static conditions. n   4. (B)
Cells were treated as in A, and p65 phosphorylation on Ser536 was as-
sessed by Western blotting. Bands were quantified by densitometry and
normalized to total p65. Values represent the increase in p65 phosphory-
lation relative to cells under static conditions. n   3. (C) Cells were ex-
posed to shear stress for 5 min and p38 phosphorylation was assessed by
Western blotting. Bands were quantified by densitometry and normalized
to total p38, and data was expressed as the fold increase in p38 phos-
phorylation compared with cells under static conditions. n   3.MATRIX REGULATES FLOW-INDUCED NF- B • ORR ET AL. 197
Ser180 for IKK  or Ser177/Ser181 for IKK ; Israel, 2000).
Shear stress stimulates NF- B activation through the integrin-
and Rac-dependent activation of IKK / , possibly through Nck-
interacting kinase (Bhullar et al., 1998; Tzima et al., 2002; Hay et
al., 2003). Immunoblotting with phospho-specific antibodies re-
veals that shear stress stimulates a matrix-specific phosphoryla-
tion profile of IKK  (Fig. 6 B) that correlated well with ac-
tivation of NF- B. These results suggest that the divergent
matrix-specific signaling occurs upstream of IKK activation. Curi-
ously, shear stress–induced IKK phosphorylation appeared to spe-
cifically target IKK . This result may be related to recent findings
that IKK  is the primary component involved in NF- B activa-
tion, whereas IKK  has distinct functions (Karin et al., 2004).
Staining of fixed cells on Coll with antibody to phospho-IKK
showed distinct colocalization of phospho-IKK with  1 integrins
in unsheared cells, which was diminished after exposure to shear
stress (Fig. 6 C). In cells on FN, phospho-IKK also colocalized
with  1 integrins, and this signal increased after shear stress. In
contrast, TNF -induced IKK phosphorylation resulted in diffuse
cytoplasmic and nuclear staining (Fig. 6 D). These results suggest
that the localized activation of p38 within integrin adhesions spe-
cifically inhibits the local, but not global, activation of NF- B.
Altering the FN matrix to inhibit NF- B
The selective activation of NF- B in atherosclerosis-prone re-
gions of the vasculature, together with the importance of NF-
 B target genes in atherosclerosis, suggest that inhibition of
this transcription factor could have therapeutic value. However,
NF- B has important roles in cell survival and immune protec-
tion, thus, global inhibition of the pathway is likely to be delete-
rious. In contrast, local inactivation of NF- B within cell–ECM
adhesions in atherosclerotic plaque could be beneficial. Al-
though FN does not normally activate p38, a peptide derived
from the first type III repeat in FN, termed III-1C, alters the
Figure 6. Localized activation of p38 and IKK at adhesion sites. (A) Cells were plated on Coll or FN, sheared for 5 min or kept under static conditions,
and stained for phosphorylated p38 and  1 integrin. Images are representative of four experiments. (B) BAE cells were plated on Coll, LN, FN, or FG and
sheared for the indicated times, and IKK phosphorylation was assessed by Western blotting. Results are representative of four to six experiments. (C) Cells
were plated on Coll or FN, sheared for 30 min or kept as static controls, and stained for phosphorylated IKK and  1 integrin. Results are representative of
three experiments. (D) Cells on Coll or FN were treated with 10 U/ml TNF  and stained for phosphorylated IKK and  1 integrin. Images are representative
of three experiments.JCB • VOLUME 169 • NUMBER 1 • 2005 198
structure of the FN matrix and stimulates p38 activation (Yi and
Ruoslahti, 2001; Klein et al., 2003). When cells on FN were
treated with this peptide, activated p38 colocalized with inte-
grins at sites of adhesion (Fig. 7, A and B). To test whether or
not FNIII-1C might also suppress NF- B activation, BAE cells
on FN were treated for 4 h with FNIII-1C or as controls with
heat denatured III-1C or the analogous peptide from the second
type III repeat, FNIII-2C. Cells were sheared for 30 min and
NF- B was assayed. FNIII-1C blocked shear stress–induced
NF- B nuclear translocation and phosphorylation, whereas
FNIII-2C and heat-denatured FNIII-1C had no effect (Fig. 7, B
and D). Furthermore, NF- B activation was rescued by p38 in-
hibition in cells treated with FNIII-1C (Fig. 7, C and D). These
results show that the proatherosclerotic FN ECM can be modi-
fied to locally activate p38 and thereby suppress NF- B.
Discussion
We present evidence that ECM composition leading to specific
integrin signals can determine the activation of NF- B by shear
stress. We also show that comparable ECM remodeling occurs
in vivo and correlates with activation of NF- B in regions of
Figure 7. FNIII-1C activates p38 and blocks shear stress–
induced NF- B activation. (A) BAE cells on FN were treated
with the FNIII-1C or FNIII-2C peptides for 4 h. Then, cells
were either left under static conditions or sheared for 30 min
and phosphorylation of p38 was assessed by Western blot-
ting with phosphorylation site-specific antibodies (n   5).
(B) Cells were plated on FN, treated with FNIII-1C for 4 h,
and stained for phosphorylated p38 and  1 integrin (n   3).
(C) BAE cells were plated on FN, incubated overnight, and
treated with 10  M FNIII1C, 10  M of heat-denatured
FNIII1C, or 10  M FNIII2C for 4 h. Cells were sheared for
30 min, and NF- B nuclear translocation was assessed by
immunocytochemistry (n   3–5). (D) Cells were pretreated
with FN peptides as in C, followed by incubation with the
p38 inhibitor SB202190 (1  M) for 1 h before onset of
shear stress. Cells were sheared for 30 min and nuclear
translocation of p65 was assessed. Values are means   SD
( 100 cells counted per condition per experiment; n   3–8).
**, P   0.01; ***, P   0.001. (E) Cells were pretreated
with the FN peptides as indicated, incubated with
SB202190, and sheared for 30 min. p65 phosphorylation at
Ser536 was assessed by Western blotting. Bands were
quantified by densitometry and normalized to total p65.
Values are means   SD from four to seven experiments. *, P  
0.05; **, P   0.01; ***, P   0.001.MATRIX REGULATES FLOW-INDUCED NF- B • ORR ET AL. 199
disturbed shear stress. Therefore, these results suggest that this
interplay might control early atherogenesis in vivo.
The role of the extracellular matrix as a key regulator of
the behavior of advanced atherosclerosis is widely accepted,
with ECM remodeling thought to affect both the size and sta-
bility of the fibrous atherosclerotic plaque (Katsuda and Kaji,
2003). However, a critical role for the subendothelial matrix in
development of atherosclerosis has not been suspected. Our
data show that deposition of FN and FG into the subendothelial
matrix in regions of disturbed flow precedes fatty streak forma-
tion in vivo. These proteins in the subendothelial matrix pro-
mote activation of NF- B by shear stress in vitro, whereas the
normal basement membrane component Coll suppresses NF- B
through  2 1-dependent p38 activation. Importantly, p38 is
activated locally within adhesion sites and prevents the shear
stress–induced activation of IKK  and NF- B but not the glo-
bal activation of NF- B by cytokines. Finally, we demonstrate
that FN matrix can be altered to stimulate p38 and suppress
shear stress–induced NF- B activation, suggesting that FN is a
possible target for therapeutic intervention.
ECM remodeling in atherogenesis
The normal subendothelial ECM is a basement membrane whose
major integrin-binding components are type IV Coll and LNs
(Yurchenco and O’Rear, 1994). Injury, inflammation, or angio-
genesis result in degradation of the basement membrane and de-
position of transitional ECM proteins such as FN and FG. We
show here that the presence of transitional matrix proteins in the
subendothelial matrix correlates with NF- B activation and target
gene expression in regions of disturbed shear stress. These data
are consistent with the idea that transitional matrix deposition reg-
ulates inflammatory gene expression in early atherogenesis; how-
ever, the causal relationships in vivo between ECM and NF- B
remain to be elucidated. Effects of disturbed flow on FN matrix
deposition could involve changes in endothelial permeability to
plasma proteins (Friedman and Fry, 1993; Phelps and DePaola,
2000; Himburg et al., 2004), changes in endothelial expression of
ECM genes (Brooks et al., 2002), or changes in integrin expres-
sion or function (Brooks et al., 2002). Identifying the mechanisms
involved in local matrix remodeling at atherosclerosis-prone sites
in arteries will be an interesting direction for future work.
We also observed marked increases in both the ECM
proteins FN and FG and the inflammatory markers ICAM-1
and VCAM-1 in atherosclerosis-susceptible regions of arteries
from ApoE null mice fed a Western diet compared with mice
on a chow diet, suggesting that the Western diet may further
increase ECM remodeling. This effect would be predicted to
further enhance endothelial responses to disturbed flow, thus
defining a positive feedback loop that would contribute to
disease progression.
Inhibition of NF- B activation by locally 
activated p38
Although p38 enhances NF- B activity in many systems (Car-
ter et al., 1999; Korus et al., 2002), there are several stimuli
for which activation of p38 inhibits NF- B, including vitamin
C, salicylate, indomethacin, sorbitol, hydrogen peroxide, and
arsenite (Schwenger et al., 1998; Alpert et al., 1999; Bowie
and O’Neill, 2000; Bradbury et al., 2001). Drosophila melano-
gaster p38 isoforms have been shown to limit antimicrobial
peptide production, a known target of D. melanogaster NF- B
(Han et al., 1998). In none of these cases has the mechanism by
which active p38 represses NF- B activation been elucidated.
Binding of integrin  2 1 to Coll also activates p38 (Ivaska et
al., 1999). Consistent with our model in which shear stress
stimulates integrin activation and ligand binding (Jalali et al.,
2001; Tzima et al., 2001; Katsumi et al., 2004), we found that
shear stress stimulated  2 1-dependent p38 activation in cells
on Coll. Activation of p38 inhibited both IKK  and NF- B ac-
tivation. Importantly, both active p38 and active IKK  local-
ized to sites of adhesion. This colocalization correlated with the
integrin specificity of the functional interaction because Coll
did not inhibit cytokine activation of NF- B and global activa-
tion of 38 did not inhibit shear stress activation of NF- B.
Therefore, the data provide a striking example where signaling
specificity is conferred by compartmentalization. Future work
will be required to elucidate the pathway by which p38 inhibits
IKK  in this system
Altering the FN matrix
Selective inhibition of NF- B activation by shear stress offers
potential benefits for treatment of atherosclerosis, but it is es-
sential that inhibitors act locally both to be effective and to
avoid global inhibition of NF- B, which would likely have un-
desirable side effects. A peptide from the first type III repeat of
FN that was reported to trigger p38 activation in cells on FN in-
duced local activation of p38 at sites of adhesion on a FN ma-
trix and inhibited shear stress–induced activation of NF- B.
The effects of FNIII-1C are poorly understood. FNIII-1C has
been reported to trigger assembly of soluble FN into fibrils and
increase matrix FN (Morla and Ruoslahti, 1992), inhibit depo-
sition of matrix FN (Bourdoulous et al., 1998), and alter its
conformation without changing the total amount of matrix
(Klein et al., 2003). Changes in FN matrix structure could con-
ceivably alter signaling through a previously bound receptor,
perhaps by changing its spatial organization, or could expose
new cell binding sites or block existing cell binding sites re-
quired to prevent p38 activation. FNIII-1C binding to FN
masks the EDA domain present in certain forms of FN (Klein
et al., 2003), which is consistent with this last hypothesis. Curi-
ously, mice engineered to lack the EDA domain of FN show re-
duced atherosclerosis, suggesting a potential role for this inter-
action in atherogenesis (Tan et al., 2004).
FNIII-1C itself is not a likely candidate for therapy, at
least as an injected reagent, because it binds to soluble FN in
the plasma and has been reported to induce assembly of this FN
into fibrils, an event that could trigger thromboses or other del-
eterious events. Thus, further investigation into the mecha-
nisms of ECM remodeling and p38 activation will be needed
to develop more suitable methods for altering subendothelial
ECM or cellular responses to it. Nevertheless, these results
point toward an entirely novel strategy for treating atheroscle-
rosis. The substrate dependence for proatherosclerotic gene ex-
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suitable signaling-based therapeutic approaches and designing
bioengineered vascular grafts.
We conclude that transitional matrix proteins, such as FN
and FG, are required for the flow-induced activation of NF- B
and suggest that deposition of FN and FG into the subendothe-
lial matrix at atherosclerosis-prone sites in vivo may regulate
the early changes in inflammatory gene expression associated
with atherogenesis. Furthermore, this shear stress–induced in-
flammatory signal appears to be inhibited by the endogenous
Coll basement membrane through integrin  2 1–dependent
activation of p38. Exploiting this fact, we show that alteration
of the FN matrix with the FNIII-1C peptide prevents the shear
stress–induced activation of NF- B through localized p38 sig-
naling. These results suggest a model in which subendothelial
matrix remodeling mediates atherosclerotic progression through
integrin-dependent mechanotransduction. Further work in which
the subendothelial matrix or integrin signals are altered will be
required to rigorously test this new model.
Materials and methods
Cell culture, parallel plate flow chamber, and transfection
BAE cells were maintained in DME containing 10% FBS, 1% penicillin/
streptomycin, and 2 mM L-glutamine (Invitrogen). Cells were plated on
38   75 mm
2 glass slides (Corning) precoated with 40  g/ml Coll I, 20
 g/ml LN, 20  g/ml FN, or 20  g/ml FG. For mixed matrix experi-
ments, slides coated with or without Coll I were subsequently coated with
increasing concentrations of FN. Western blotting was used to determine
the amount of FN adsorbed to the dishes with and without Coll coating.
After 4 h, cells were fully attached and spread and formed a confluent
monolayer. Slides were loaded onto a parallel plate flow chamber in ei-
ther 0.1% BSA or 0.5% FBS and 12 dynes/cm
2 of shear stress was ap-
plied for varying times. Transient transfection of dominant-negative p38
(AGF mutation; 10  g/ml) and constitutively active MKK3 (EE mutation;
10  g/ml) was performed by electroporation at 170 V and 960  F. Cells
were replated and incubated for 48 h to allow protein expression before
loading onto glass slides for exposure to shear stress.
Immunocytochemistry
Cells were fixed with PBS containing 2% formaldehyde, permeabilized
with 0.2% Triton X-100 when applicable, and blocked overnight in PBS
containing 1% BSA and 10% goat serum. Primary antibodies were incu-
bated with cells in blocking buffer as follows: rabbit anti-p65 (Santa Cruz
Biotechnology, Inc.; 1:200 for 1 h), rabbit anti-ICAM (Santa Cruz Biotech-
nology, Inc.; 1:100 for 1 h), rabbit anti–phospho-IKK (Cell Signaling Tech-
nology; 1:100 overnight), rabbit anti–phospho-p38 (Cell Signaling Tech-
nology; 1:100 overnight), and mouse anti-ligated  1 integrins (12G10; 1
 g/ml for 1 h). Cells were incubated in 1  g/ml Alexa 488–conjugated
goat anti–rabbit IgG or Alexa 568–conjugated goat anti–mouse IgG
(Molecular Probes). Slides were mounted with Fluoromount G and im-
ages were taken using the 60  oil immersion objective on a microscope
(model DiaPhot; Nikon) equipped with a CoolSnap video camera (Photo-
metrics) using the Inovision ISEE software program.
Immunoblotting
Cell lysis and immunoblotting were performed as previously described
(Orr et al., 2002). Rabbit anti–phospho-p38 (Cell Signaling Technology),
mouse anti-p38 (Santa Cruz Biotechnology, Inc.), rabbit anti–phospho-
p65 (Ser536; Cell Signaling Technology), rabbit anti-p65 (Santa Cruz
Biotechnology, Inc.), rabbit anti–phospho-IKK /  (Cell Signaling Technol-
ogies), and rabbit anti-IKK /  (Santa Cruz Biotechnology, Inc.) were all
used at 1:1000 dilutions.
Animals
Six male ApoE-deficient mice on a C57BL/6 background (Jackson Immu-
noResearch Laboratories), 8–12 wk old and weighing 18–20 g, were
used in these experiments. Four mice were fed a Western-type athero-
genic diet (TD 88137; Harlan-Teklad; containing 21% fat by weight,
0.15% by weight cholesterol, and 19.5% by weight casein without so-
dium cholate) for 10 wk before killing. Control mice were fed a chow diet
during this time. Comparable wild-type C57/B6 mice were fed the chow
diet during the same time frame.
Vessel harvest
At 20 wk old (10 wk on diet), mice were perfused with 4% formaldehyde
and the innominate, left carotid, right carotid, and short segments of the
descending abdominal aorta near the renal arteries and the iliac bifurca-
tion were processed for paraffin embedding.
IHC
5- m paraffin sections were obtained for IHC. IHC for adhesion molecules
VCAM-1, ICAM-1, Mac-2, and PECAM-1 (Santa Cruz Biotechnology,
Inc.) was performed as previously described (McPherson et al., 2001). Af-
ter microwave antigen retrieval with antigen unmasking solution (Vector
Laboratories), rabbit anti-FN (1:400; Sigma-Aldrich) and rabbit anti-LN
(1:500; Sigma-Aldrich) were applied. Detection of antibodies was done
with Vectastain Elite Kit (Vector Laboratories). Visualization was done with
DAB (Deko Corp). Goat anti-FG (1  g/ml; Accurate Chemical) was ap-
plied as for the other antigens, except that no antigen retrieval was re-
quired. Images were acquired using the 20 or 40  objective on a micro-
scope (model BX51; Olympus) equipped with a digital camera (model
DP70; Olympus) using the ImagePro Plus software program in the Aca-
demic Computing Health Sciences Center at the University of Virginia.
Online supplemental material
In Fig. 4, we demonstrate that incubation with the  2 1 integrin–blocking
antibody R2-8C8 can block shear-induced p38 activation on Coll and res-
cue NF- B activation in cells on Coll, presumably by preventing the inter-
action of newly activated  2 1 with Coll. To demonstrate that this effect
was not due to changes in cell adhesiveness, we show that short-term incu-
bation with R2-8C8 does not affect the organization of the actin cytoskele-
ton (Fig. S1). To show that this effect was specific to Coll, we also pre-
vented the interaction between  6 1 and LN with the  6 1-blocking
antibody GoH3, which did not rescue flow-induced NF- B activation (Fig.
S2). Finally, we show that flow-induced p38 activation on Coll prevents
flow-dependent activation of NF- B. To determine if this effect was specific
for flow, the ability of TNF  to activate NF- B in cells on different matrix
proteins or overexpressing a constitutively active MKK3 construct (MKK3-
EE) was assessed (Fig. S3). Online supplemental material is available at
http://www.jcb.org/cgi/content/full/jcb.200410073/DC1.
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